Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

NCT04776096 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Bepotastine Besilate 1.5% PF
DRUG: Olopatadine Hydrochloride 0.2% BAK

Sponsor

Laboratorios Poen